- Q4 2023 Almirall SA Earnings Call TranscriptFeb 19, 2024€9.1 (+5.63%)Earnings
- Almirall SA at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Nine Months 2023 Almirall SA Earnings Call TranscriptNov 09, 2023€8.59 (-1.66%)Earnings
- Half Year 2023 Almirall SA Earnings Call TranscriptJul 24, 2023€8.52 (+0.35%)Earnings
- Q1 2023 Almirall SA Earnings Call TranscriptMay 08, 2023€8.9 (+0.17%)Earnings
- Full Year 2022 Almirall SA Earnings Presentation TranscriptFeb 20, 2023
- Almirall SA at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Almirall SA Earnings Call TranscriptNov 10, 2022€9.15 (+0.72%)Earnings
- Half Year 2022 Almirall SA Earnings Call TranscriptJul 25, 2022€9.94 (-2.93%)Earnings
- Q1 2022 Almirall SA Earnings Call TranscriptMay 09, 2022€10.26 (-11.40%)Earnings
- Almirall SA Lebrikizumab ADVocate 1 and 2 Call TranscriptMar 30, 2022
- Full Year 2021 Almirall SA Earnings Call TranscriptFeb 21, 2022€11.5 (+8.29%)Earnings
- Almirall SA at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Almirall SA Earnings Presentation TranscriptNov 15, 2021
- Half Year 2021 Almirall SA Earnings Call TranscriptJul 26, 2021€13.21 (-11.64%)Earnings
- Almirall SA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 Almirall SA Earnings Call TranscriptMay 10, 2021€13.98 (+8.37%)Earnings
- Full Year 2020 Almirall SA Earnings Call TranscriptFeb 22, 2021€11.69 (-1.52%)Earnings
- Q3 2020 Almirall SA Earnings Call TranscriptNov 09, 2020€10.53 (+6.26%)Earnings
- Half Year 2020 Almirall SA Earnings Call TranscriptJul 27, 2020€9.87 (-1.30%)Earnings
- Almirall SA at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 12, 2020
- Q1 2020 Almirall SA Earnings Call TranscriptMay 11, 2020€11.84 (-6.77%)Earnings
- Full Year 2019 Almirall SA Earnings Call TranscriptFeb 24, 2020€12.35 (-2.53%)Earnings
- Almirall SA at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Almirall SA Earnings Call TranscriptNov 11, 2019€17 (-1.90%)Earnings
- Half Year 2019 Almirall SA Earnings Call TranscriptJul 29, 2019€17.3 (-4.10%)Earnings
- Almirall SA License Agreement of lebrikizumab for Atopic Dermatitis in Europe Conference Call TranscriptJun 25, 2019
- Q1 2019 Almirall SA Earnings Call TranscriptMay 13, 2019€15.56 (+0.13%)Earnings
- Full Year 2018 Almirall SA Earnings Call TranscriptFeb 25, 2019Earnings
Almirall SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning, good afternoon, everyone. My name is Krishna Chaitanya Arikatla or K.C. Arikatla, and I cover European mid-cap pharma and life sciences companies for Goldman Sachs. It's my pleasure to have Mike McClellan CFO of Almirall; and Pablo Divasson, Head of Investor Relations at Almirall with us today.
In terms of the format for the session, it would be pretty interactive with Q&A starting right away. If you have any questions, please input your questions on the interface that you have on the right side, and I'll do my best efforts to ask those questions to management.
Questions & Answers
Now moving on to questions, Mike, on 2021 guidance, you've had a very strong Q1, with good performance across all the key growth drivers. How should we think about the guidance in that context? Do you think it's quite conservative? And how should we think about a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)